This will in my opinion be an institutional investor emerging from the 'Broker meet Biotech' presentation ANN of 28th May 2015.
Unexpected 'Investor presentations' often precede a CR in Biotech and Mining companiesthat should have been an eye opener to existing shareholders.
Holmeseath01 good question mate. I probably don't know the answer to that one. A guess would be it is over 15% of issued capital where shareholder approval is required; which also means shareholders can exercise their option to block this CR or ask for a rights issue before the Insto placement.
IMHO; Your thoughts beautiful people !!
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |